• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Abstract arrangement of geometric shapes including spheres a pyramid and balancing wooden and stone slabs
Biotech

82% of industry CEOs concerned about FDA's abilities: survey

Biotech CEOs worry that added volatility in an already high-risk industry will discourage investment or will drive it to other countries.
Gabrielle Masson Nov 21, 2025 4:38pm
monkeys

CDC orders researchers to end all monkey studies: Science

Nov 21, 2025 1:15pm
now hiring

FDA unveils hiring spree, new comms program to speed reviews

Nov 21, 2025 11:43am
person throwing away garbage or recycling

Moderna winds down 3 mRNA programs

Nov 20, 2025 4:10pm
blood test vial

Roche inks $200M pact for Freenome's cancer screening blood test

Nov 21, 2025 10:55am
locking horns fight battle lock horns
Favicon Fierce Pharma

GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement

Nov 21, 2025 9:46am
More News

Gilead abruptly parts ways with general counsel—Chutes & Ladders

Nov 21, 2025 8:30am

Fierce Biotech Layoff Tracker 2025: Ensoma, Applied Tx & more

Nov 21, 2025 7:00am

Nurix trims staff as trial for lead BTK degrader kicks off

Nov 21, 2025 5:05am

Contineum-J&J drug fails to improve vision in phase 2 MS trial

Nov 20, 2025 5:26pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings